News Detail
Mumbai, 1 Feb 2023: With reference to the re-stickering of price controlled scheduled drugs and National List of Essential Medicines (NLEM), the Drugs Controller General of India (DCGI) has issued a circular to the state drug controllers (SDCs) stating that it has no objection fo......
View Details
Source : Pharmabiz
re-stickering
NLEM
DCGI
SDCs
Rule 104A of Drugs Rules
D Rules
NPPA
CDSCO
Torrent Pharmaceuticals
MRP
Related News
- Zydus gets warning as FDA highlights glass contamination concerns and others (12-09-2024)
- MPIDC allotted land to 36 industries in Medical Devices Park, investment of 1.8k crore (12-09-2024)
- DCC asks states and UTs to ensure implementation of revised Schedule M (12-09-2024)
- NPPA fixes retail price of 62 new drugs, extends CP of knee implants (12-09-2024)
- US FDA Issues Revised Guidance On Controlling Nitrosamine Impurities In Pharmaceuticals (12-09-2024)
- Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine (12-09-2024)
- DCGI suspends permission to Entod pharma's 'Presvu Eye Drops', company to challenge order in court (11-09-2024)
- Diagnostic kits for early detection of Alzheimer’s and cancer launched (11-09-2024)
- FDI equity inflow into pharma sector grows to $236 million in Q1FY25 (11-09-2024)
- Steroid Use Could Raise Diabetes Risk (11-09-2024)